These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 19772197)
21. An exploratory dimensional approach to premenstrual manifestation of obsessive-compulsive disorder symptoms: a multicentre study. Moreira L; Bins H; Toressan R; Ferro C; Harttmann T; Petribú K; Juruena MF; do Rosário MC; Ferrão YA J Psychosom Res; 2013 Apr; 74(4):313-9. PubMed ID: 23497833 [TBL] [Abstract][Full Text] [Related]
22. [The treatment of the resistant obsessive-compulsive disorder: an update]. Crespo Facorro B; Gomez-Hernández R Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(1):61-9. PubMed ID: 9133159 [TBL] [Abstract][Full Text] [Related]
23. Hoarding in obsessive-compulsive disorder: a report of 20 cases. Winsberg ME; Cassic KS; Koran LM J Clin Psychiatry; 1999 Sep; 60(9):591-7. PubMed ID: 10520977 [TBL] [Abstract][Full Text] [Related]
24. Clinicians' views on clinical examination and treatment of children and adolescents with obsessive-compulsive disorder (OCD). A Danish national survey study. Nissen JB; Thomsen PH Nord J Psychiatry; 2008; 62(4):309-14. PubMed ID: 18763190 [TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy for obsessive-compulsive disorder. Hollander E; Kaplan A; Allen A; Cartwright C Psychiatr Clin North Am; 2000 Sep; 23(3):643-56. PubMed ID: 10986733 [TBL] [Abstract][Full Text] [Related]
29. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Fineberg NA; Gale TM Int J Neuropsychopharmacol; 2005 Mar; 8(1):107-29. PubMed ID: 15450126 [TBL] [Abstract][Full Text] [Related]
30. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study. Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424 [TBL] [Abstract][Full Text] [Related]
31. A review of pharmacologic treatments for obsessive-compulsive disorder. Kaplan A; Hollander E Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138 [TBL] [Abstract][Full Text] [Related]
32. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Gilbert AR; Moore GJ; Keshavan MS; Paulson LA; Narula V; Mac Master FP; Stewart CM; Rosenberg DR Arch Gen Psychiatry; 2000 May; 57(5):449-56. PubMed ID: 10807485 [TBL] [Abstract][Full Text] [Related]
35. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Haghighi M; Jahangard L; Mohammad-Beigi H; Bajoghli H; Hafezian H; Rahimi A; Afshar H; Holsboer-Trachsler E; Brand S Psychopharmacology (Berl); 2013 Aug; 228(4):633-40. PubMed ID: 23525525 [TBL] [Abstract][Full Text] [Related]
36. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014 [TBL] [Abstract][Full Text] [Related]